As the life sciences industry continues to undergo significant changes, Reed Smith is committed to offering high quality, free educational opportunities for its pharmaceutical, medical device, and biotechnology clients. We thus are pleased to shared two upcoming opportunities with you.
First, because the new import tariffs proposed by the current administration could significantly affect life sciences companies, Reed Smith partner Mike Lowell and associate Jeff Orenstein are offering a free CLE webinar that will provide practical information on the new tariffs and what they could mean for your business. This program is presumptively approved for 1.0 general CLE credit in California, Illinois, New Jersey, Pennsylvania, Texas and West Virginia. For lawyers licensed in New York, this course is eligible for 1.0 credit under New York’s Approved Jurisdiction Policy. An application for 1.0 HRCI credit is currently pending. To register for this free CLE webinar, please click here.
Additionally, Reed Smith’s London office will be hosting a distinguished panel to discuss “Equity Capital Markets in the Pharmaceutical and Biotech Industry” on May 22. Speakers include Reed Smith’s James Wilkinson and Fiona McFarlane, as well as Mitesh Patelia of Crowe Clark Whitehill, Vadim Alexandre of Northland Capital Partners, and Dr. Dmitry Kuzmin of 4BIO Capital. To register for the event, please click here.